Carsten Schroeder
Chief Executive Officer bei Grifols Diagnostic Solutions, Inc.
Profil
Carsten Schroeder is currently the Chief Executive Officer at MicroVention, Inc., Grifols Diagnostic Solutions, Inc., and Director at MicroVention UK Ltd.
Previously, he held positions as Director at Singulex, Inc., Non-Executive Director at Oncimmune Ltd., Independent Non-Executive Director at Oncimmune Holdings Plc from 2016 to 2020, President-Diagnostic Division at Grifols SA, Vice President-Commercial Operations at Novartis Vaccines & Diagnostics SL in 2010, and President-Diagnostics Division at Novartis Farmacéutica SA. Dr. Schroeder completed his undergraduate degree at Universität zu Köln and holds an MBA from ESCP Europe Campus Paris.
Aktive Positionen von Carsten Schroeder
| Unternehmen | Position | Beginn |
|---|---|---|
Grifols Diagnostic Solutions, Inc.
 Grifols Diagnostic Solutions, Inc. Pharmaceuticals: MajorHealth Technology Grifols Diagnostic Solutions, Inc. manufactures and markets plasma medicines and medical tools. Its services include blood group genotyping testing, IRL serology testing, prenatal testing, biological drug monitoring tests, FH genetic testing and other genetic testing. The company is headquartered in Emeryville, CA. | Chief Executive Officer | - |
MicroVention, Inc.
 MicroVention, Inc. Medical SpecialtiesHealth Technology Microvention, Inc. develops and markets medical devices for the treatment of vascular diseases. Its products include platinum and hydrogel coils, V-trak system, access products, and intraluminal devices. The company was founded by Robert F. Rosenbluth in April 1997 and is headquartered in Aliso Viejo, CA. | Chief Executive Officer | - |
MicroVention UK Ltd.
 MicroVention UK Ltd. Medical SpecialtiesHealth Technology Part of Terumo Corp., MicroVention UK Ltd. is a private company that manufactures and supplies transfusion & infusion medical equipment & other medical devices. The company is based in North Shields, UK. MicroVention was founded in 2002. | Director/Board Member | - |
Ehemalige bekannte Positionen von Carsten Schroeder
| Unternehmen | Position | Ende |
|---|---|---|
| ONCIMMUNE HOLDINGS PLC | Director/Board Member | 04.06.2020 |
| Novartis Vaccines & Diagnostics SL | Corporate Officer/Principal | 01.11.2010 |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Director/Board Member | - |
| Novartis Farmacéutica SA | Corporate Officer/Principal | - |
| GRIFOLS, S.A. | Corporate Officer/Principal | - |
Ausbildung von Carsten Schroeder
| Universität zu Köln | Undergraduate Degree |
| ESCP Europe Campus Paris | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GRIFOLS, S.A. | Health Technology |
| ONCIMMUNE HOLDINGS PLC | Health Technology |
| Private Unternehmen | 7 |
|---|---|
MicroVention, Inc.
MicroVention, Inc. Medical SpecialtiesHealth Technology Microvention, Inc. develops and markets medical devices for the treatment of vascular diseases. Its products include platinum and hydrogel coils, V-trak system, access products, and intraluminal devices. The company was founded by Robert F. Rosenbluth in April 1997 and is headquartered in Aliso Viejo, CA. | Health Technology |
Singulex, Inc.
 Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Commercial Services |
Grifols Diagnostic Solutions, Inc.
Grifols Diagnostic Solutions, Inc. Pharmaceuticals: MajorHealth Technology Grifols Diagnostic Solutions, Inc. manufactures and markets plasma medicines and medical tools. Its services include blood group genotyping testing, IRL serology testing, prenatal testing, biological drug monitoring tests, FH genetic testing and other genetic testing. The company is headquartered in Emeryville, CA. | Health Technology |
| Novartis Vaccines & Diagnostics SL | |
| Novartis Farmacéutica SA | |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
MicroVention UK Ltd.
MicroVention UK Ltd. Medical SpecialtiesHealth Technology Part of Terumo Corp., MicroVention UK Ltd. is a private company that manufactures and supplies transfusion & infusion medical equipment & other medical devices. The company is based in North Shields, UK. MicroVention was founded in 2002. | Health Technology |
